Cost Effectiveness of Pcv13 Vs Ppsv23 For The Immunization of Adults Over 65 Years with Low or Moderate Risk of Pneumococcal Infection
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.2914
https://www.valueinhealthjournal.com/article/S1098-3015(17)33248-5/fulltext
Title :
Cost Effectiveness of Pcv13 Vs Ppsv23 For The Immunization of Adults Over 65 Years with Low or Moderate Risk of Pneumococcal Infection
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)33248-5&doi=10.1016/j.jval.2017.08.2914
First page :
A931
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2685